Technical Analysis for INMB - INmune Bio Inc.

Grade Last Price % Change Price Change
B 20.14 4.08% 0.79
INMB closed up 4.08 percent on Friday, September 24, 2021, on 70 percent of normal volume.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Up
Historical INMB trend table...

Date Alert Name Type % Chg
Multiple of Ten Bullish Other 0.00%
Wide Bands Range Expansion 0.00%
Up 3 Days in a Row Strength 0.00%
Up 4 Days in a Row Strength 0.00%
Oversold Stochastic Weakness 0.00%
50 DMA Support Bullish 4.08%
Wide Bands Range Expansion 4.08%
Up 3 Days in a Row Strength 4.08%
Oversold Stochastic Weakness 4.08%
Crossed Above 50 DMA Bullish 4.84%
Older End-of-Day Signals for INMB ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

INmune Bio, Inc. is a clinical-stage biotechnology company developing therapies targeting the innate immune system in cancer. INmune Bio is developing two products platforms that reengineer the patient’s innate immune system’s response to their cancer, INKmune and INB03. INKmune is a Natural Killer (NK) cell therapeutic that primes the patient’s NK cells to attack developing disease. INB03 inhibits myeloid derived suppressor cells (MDSC), which often cause resistance to immunotherapy, such as anti-PD1 checkpoint inhibitors. INmune Bio’s product platforms target residual disease and utilize a precision medicine approach for treatment of a wide variety of hematologic malignancies and solid tumors.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Cancer Solid Tumors Immune System Immunotherapy Disease Cancer Treatments Precision Medicine Hematologic Malignancies Checkpoint Inhibitor Tumors Of The Hematopoietic And Lymphoid Tissues Mdsc Residual Disease

Is INMB a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 30.37
52 Week Low 7.28
Average Volume 531,924
200-Day Moving Average 16.43
50-Day Moving Average 18.90
20-Day Moving Average 20.95
10-Day Moving Average 18.53
Average True Range 2.09
ADX 16.81
+DI 26.10
-DI 23.42
Chandelier Exit (Long, 3 ATRs) 24.09
Chandelier Exit (Short, 3 ATRs) 23.10
Upper Bollinger Bands 27.02
Lower Bollinger Band 14.87
Percent B (%b) 0.43
BandWidth 58.00
MACD Line -0.13
MACD Signal Line 0.12
MACD Histogram -0.2481
Fundamentals Value
Market Cap 270.84 Million
Num Shares 13.4 Million
EPS -0.62
Price-to-Earnings (P/E) Ratio -32.59
Price-to-Sales 0.00
Price-to-Book 2.84
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 22.95
Resistance 3 (R3) 22.87 21.86 22.48
Resistance 2 (R2) 21.86 21.15 21.90 22.32
Resistance 1 (R1) 21.00 20.70 21.43 21.08 22.17
Pivot Point 19.99 19.99 20.21 20.03 19.99
Support 1 (S1) 19.13 19.28 19.56 19.21 18.11
Support 2 (S2) 18.12 18.83 18.16 17.96
Support 3 (S3) 17.26 18.12 17.80
Support 4 (S4) 17.34